BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12767068)

  • 1. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
    Wang YQ; Ugai S; Shimozato O; Yu L; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Tagawa M
    Int J Cancer; 2003 Jul; 105(6):820-4. PubMed ID: 12767068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
    Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M
    Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
    Ugai S; Shimozato O; Kawamura K; Wang YQ; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects.
    Ugai S; Shimozato O; Yu L; Wang YQ; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Oct; 10(10):771-8. PubMed ID: 14502230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
    Shimozato O; Ugai S; Chiyo M; Takenobu H; Nagakawa H; Wada A; Kawamura K; Yamamoto H; Tagawa M
    Immunology; 2006 Jan; 117(1):22-8. PubMed ID: 16423037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.
    Shan BE; Hao JS; Li QX; Tagawa M
    Cell Mol Immunol; 2006 Feb; 3(1):47-52. PubMed ID: 16549049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells.
    Chiyo M; Shimozato O; Iizasa T; Fujisawa T; Tagawa M
    Anticancer Res; 2004; 24(6):3763-7. PubMed ID: 15736409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
    Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice.
    Shan B; Yu L; Shimozato O; Li Q; Tagawa M
    Anticancer Res; 2004; 24(1):79-82. PubMed ID: 15015579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
    Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.
    Tasaki K; Yoshida Y; Miyauchi M; Maeda T; Takenaga K; Kouzu T; Asano T; Ochiai T; Sakiyamna S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):255-61. PubMed ID: 10770634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antitumor activity of interleukin-27.
    Hisada M; Kamiya S; Fujita K; Belladonna ML; Aoki T; Koyanagi Y; Mizuguchi J; Yoshimoto T
    Cancer Res; 2004 Feb; 64(3):1152-6. PubMed ID: 14871851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
    Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
    Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity.
    Mendiratta SK; Quezada A; Matar M; Wang J; Hebel HL; Long S; Nordstrom JL; Pericle F
    Gene Ther; 1999 May; 6(5):833-9. PubMed ID: 10505108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
    Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
    Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and antimetastatic activity of IL-23.
    Lo CH; Lee SC; Wu PY; Pan WY; Su J; Cheng CW; Roffler SR; Chiang BL; Lee CN; Wu CW; Tao MH
    J Immunol; 2003 Jul; 171(2):600-7. PubMed ID: 12847224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of endogenously produced interferon gamma in interleukin 4-mediated tumor rejection.
    Nishihori H; Tsuji H; Wang H; Tahara H; Akiyama M; Ogawa Y; Matsushima K; Iwakura Y; Mukaida N
    Hum Gene Ther; 2000 Mar; 11(5):659-68. PubMed ID: 10757346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.